Rajeev Soni

Dr. Rajeev Soni (ORCID ID : 0000-0001-7126-5864) has a Ph.D. in Biotechnology from the University of Cambridge, UK and has 25 years of experience working across the globe in various institutes and multinationals such as The Scripps Research Institute, Novartis, Novozymes, Ranbaxy, Biocon, Biomerieux and as a principal investigator with US Naval Research Lab in drug discovery, molecular diagnostics, protein expression, biologic manufacturing and business development.

2024 Nobel Prize in Medicine for discovery of “microRNA and new Principle of Gene regulation”

The 2024 Nobel Prize in Physiology or Medicine has been awarded jointly to Victor Ambros and Gary Ruvkun “for the discovery of microRNA and...

Discovery of a novel human protein that functions as RNA ligase: first report of such protein in higher eukaryotes 

RNA ligases play an important role in RNA repair, thereby maintaining RNA integrity. Any malfunction in RNA repair in humans seems to be associated...

Status of Universal COVID-19 Vaccine: An Overview

The search for a universal COVID-19 vaccine, effective against all present and future variants of coronaviruses is an imperative. The idea is to focus on...

COVID-19 in England: Is Lifting of Plan B Measures Justified?

The government in England recently announced lifting of plan B measures amidst ongoing Covid-19 cases, that makes mask wearing not mandatory, dropping of work...

The Gene variant that protects against severe COVID-19

A gene variant of OAS1 has been implicated in reducing the risk of severe COVID-19 disease. This warrants developing agents/drugs that can increase the...

Future of Adenovirus based COVID-19 Vaccines (such as Oxford AstraZeneca) in light of recent finding about Cause of rare side effects of Blood clot

Three adenoviruses used as vectors to produce COVID-19 vaccines, bind to platelet factor 4 (PF4), a protein implicated in the pathogenesis of clotting disorders.  Adenovirus...

Soberana 02 and Abdala: World’s first Protein conjugate Vaccines against COVID-19

The technology used by Cuba to develop protein-based vaccines against COVID-19 can lead to development of vaccines against new mutated strains in a relatively...

Spinal Cord Injury (SCI): Exploiting Bio-active Scaffolds to Restore Function

Self-assembled nanostructures formed using supramolecular polymers containing peptide amphiphiles (PAs) containing bio active sequences have shown great results in mouse model of SCI and holds immense promise, in...

Stay in touch:

87,735FansLike
45,089FollowersFollow
1,772FollowersFollow

Newsletter

Don't miss

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...